Healthcare tech company Trialbee AB has announced a change in leadership that sees Matt Walz appointed Chief Executive Officer. Mr. Walz replaced Dr. Lollo Eriksson, who will transition to the role of Chief Strategy Officer.
“I am pleased and thankful for the support the Trialbee Board of Directors have been providing in the search of a new and strong long-term technology experienced leader for the company,” said Dr. Eriksson. “I am thrilled to work with Matt and continue developing our existing and new strategic approaches and partnerships to realize the best quality and value to our customers and shareholders.”
Mr. Walz is an expert in building software platforms and advising strategies, with more than 20 years of experience in the life sciences and tech industries. He co-founded NextDocs Corporation, where he served as Chief Strategy Officer and Chief Technology Officer.
“The pandemic has made the world aware of the importance of clinical trials, and the critical role they play in connecting new drugs, therapies and devices with the patients that need them most,” said Mr. Walz. “I am humbled by the opportunity to lead Trialbee’s strong management team as we work to achieve the mission of simplifying the patient journey in clinical research through digital patient matching and engagement."